qanastek/EMEA-V3 huggingface dataset:
If you are treated with Levemir Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
Jekk inti qed tkun ittrattat/ a b’ Levemir Penfill u bi skartoċċ ieħor ta ’ l- insulina tal- Penfill, għandek tuża żewġ sistemi li jerħu l- insulina, waħda għal kull tip ta ’ insulina.
Levemir is for injection under the skin (subcutaneously).
Levemir għandu jiġi injettat taħt il- ġilda.
Never inject your insulin directly into a vein or muscle.
Qatt m’ għandek tinjetta l- insulina tiegħek direttament ġo vina jew muskolu.
Always vary the sites you inject within the same region, to avoid lumps (see 5 Possible side effects).
Dejjem ibdel il- partjiet minn fejn tinjetta, fl- istess żona tal- ġisem, biex tevita ħotbiet (ara 5 Effetti sekondarji li jista ’ jkollu).
The best places to give yourself an injection are: the front of your thighs; the front of your waist (abdomen), or the upper arm.
L- aħjar postijiet minn fejn tinjetta lilek innifsek huma: in- naħa ta ’ quddiem tal- koxox; in- naħa ta ’ quddiem tal- qadd (iż- żaqq), jew fin- naħa ta ’ fuq tad- driegħ.
You should always measure your blood glucose regularly.
Għandek dejjem tkejjel il- livell ta ’ zokkor fid- demm tiegħek regolarment.
How to inject this insulin
Kif għandek tinjetta din l- insulina
Use the injection technique advised by your doctor or diabetes nurse and described in your delivery system manual • Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered • After each injection be sure to remove and discard the needle and store Levemir without the needle attached.
Uża t- teknika ta ’ l- injezzjoni kif irrikkmandat mit- tabib tiegħek jew ners u kif hemm imfisser fil- manwâl tas- sistema ta ’ l- għoti. • Żomm il- labra taħt il- ġilda tiegħek għal mill- inqas 6 sekondi biex tiżgura li d- doża kollha tkun ingħatat. • Wara kull injezzjoni kun ċert li tneħħi u tarmi l- labra u aħżen Levemir mingħajr ma l- labra tkun imwaħħla.
Otherwise, the liquid may leak out, which can cause inaccurate dosing.
Inkella, il- likwidu jista ’ jnixxi ’ l barra li jista ’ jagħti l- każ li tingħata doża żbaljata.
WHAT TO DO IN AN EMERGENCY
X’ GĦANDEK TAGĦMEL F’ KAŻ TA ’ EMERĠENZA
This may happen: • If you take too much insulin • If you eat too little or miss a meal • If you exercise more than usual.
Dan jista ’ jiġri: • Jekk tieħu wisq insulina • Jekk tiekol ftit wisq jew taqbeż xi ikla • Jekk tagħmel aktar eżercizzju mis- soltu.
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Is- sinjali ta ’ twissija ta ’ ipo jistgħu jiġu għall- għarrieda u jistgħu jinkludu: għaraq kiesaħ; ġilda friska u ċara; uġigħ ta ’ ras; taħbit tal- qalb mgħaġġel; tħossok imdardar; tħossok bil- ġuħ ħafna; tibdil temporanju fil- vista; ngħas; għeja jew dgħjufija mhux tas- soltu; nervożiżmu jew rogħda; tħossok anzjuż/ a; tħossok konfuż/ a; tħoss diffikultà biex tikkonċentra.
If you feel a hypo coming on: take a high sugar snack and then measure your blood sugar.
Jekk tħoss li ġejja ipo: ħu ikla ħafifa li fiha ħafna zokkor u mbagħad kejjel il- livell tal- glukosju fid - demm.
Always carry glucose tablets, sweets, biscuits or fruit juice with you, just in case.
Dejjem żomm fuqek kapsuli tal- glukosju, ħelu, gallettini jew meraq tal- frott, għal li jista ’ jkun.
If your blood sugar is too low: eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest.
Jekk il- livell taz- zokkor fid- demm ikun baxx ħafna: ħu kapsuli tal- glukosju jew kul ikla ħafifa li fiha ħafna zokkor (ħelu, gallettini, meraq tal- frott), u mbagħad strieħ.
When symptoms of hypoglycaemia have disappeared or when blood glucose levels are stabilised continue insulin treatment.
Meta s- sintomi ta ’ ipogliċemija jkunu għebu jew meta l- livelli tal- glukosju jkunu stabbilizzaw, kompli bil- kura ta ’ l- insulina.
Tell people you have diabetes and what may be the consequences, including the risk of passing out due to a hypo.
Għid lin- nies li għandek id- dijabete u x’ jistgħu jkunu l- konsegwenzi, li jinkludu r- riskju li tintilef minn sensik minħabba ipo.
Tell people that if you pass out (become unconscious), they must turn you on your side and get medical help straight away.
Għid lin- nies li jekk iħossok ħażin (tintilef minn sensik), huma għandhom idawwruk fuq ġenbek u jitolbu għajnuna medika mill- aktar fis.
They must not give you any food or drink.
Dan jista ’ jifgak.
It could choke you. ► If prolonged severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death ► If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor.
Jekk ipogliċemija serja fit- tul ma tkunx ittrattata, din tista tikkawża ħsara fil- moħħ ► (temporanja jew permanenti) u anke l- mewt.
The amount or timing of insulin, food or exercise may need to be adjusted.
Jekk għandek ipo li jġiegħlek tintilef minn sensik, jew ħafna ipos, kellem lit- tabib tiegħek. ► Jista ’ jkun hemm bżonn li jiġi aġġustat il- ħin ta ’ l- insulina, l- ikel jew l- eżerċizzju.
You may recover more quickly from unconsciousness with an injection of the hormone glucagon by someone who knows how to use it.
Jekk tintilef minn sensik, tista ’ tirkupra aktar malajr b’ injezzjoni ta ’ l- ormon glucagon minn xi ħadd li jaf kif jużah.
If you are given glucagon you will need glucose or a sugary snack as soon as you are conscious.
Jekk tingħata glucagon inti jkollok bżonn il- glukosju jew kul ikla ħafifa li fiha z- zokkor hekk kif terġa ’ tiġi f’ sensik.
If you do not respond to glucagon treatment, you will have to be treated in a hospital.
Jekk ma tirrispondix għat- trattament bi glucagon, int ikollok bżonn ta ’ kura fl- isptar.
Contact your doctor or an emergency ward after an injection of glucagon: you need to find the reason for your hypo to avoid getting more.
Ikkuntattja lit- tabib tiegħek jew lit- taqsima ta ’ l- emerġenza wara injezzjoni ta ’ glucagon: inti teħtieġ li ssib raġuni għall- ipo tiegħek biex tevita li jkollok iktar.
Your blood sugar may get too high (this is called hyperglycaemia).
Il- livell taz- zokkor fid- demm tiegħek jitla ’ żżejjed (dan jissejjaħ ipergliċemija).
The warning signs appear gradually.
Is- sinjali tat- twissija jibdew jidhru gradwalment.
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed, dry skin; dry mouth and a fruity (acetone) smell of the breath.
Dawn jinkludu: żjieda fl- għamil ta ’ l- awrina; tħossok bil- għatx; titlef l- aptit; tħossok imdardar (dardir jew rimettar); tħossok bi ngħas jew għajjien/ a; ġilda xotta u ħamra; ħalq xott, u riħa ta ’ frott (aċetun) fin- nifs.
If you get any of these signs: test your blood sugar level, test your urine for ketones if you can, then seek medical advice straight away.
Jekk ikollok xi wieħed minn dawn is- sinjali: ittestja l- livell taz- zokkor fid- demm tiegħek, ittestja l - awrina tiegħek għal ketoni jekk tista ’, imbagħad fittex għajnuna medika malajr kemm jista ’ jkun.
These may be signs of a very serious condition called diabetic ketoacidosis.
Dawn jistgħu jkunu sinjali ta ’ kondizzjoni serja ħafna li tissejjaħ ketoaċidożi dijabetika.
If you don ’ t treat it, this could lead to diabetic coma and death.
Jekk ma tittrattahiex, din tista ’ twassal għal koma dijabetika u mewt.
• Having forgotten to take your insulin • Repeatedly taking less insulin than you need • An infection or a fever • Eating more than usual • Less exercise than usual.
• Tinsa tieħu l- insulina tiegħek • Li ripetutament tieħu inqas insulina milli teħtieġ • Infezzjoni jew deni • Tiekol aktar mis- soltu • Tagħmel eżerċizzju inqas mis- soltu
Like all medicines, Levemir can cause side effects, although not everybody gets them.
Bħal kull mediċina oħra, Levemir jista ’ jkollu effetti sekondarji, għalkemm ma jidhrux fuq kulħadd.
Taking too much Levemir may cause low blood sugar (hypoglycaemia).
Jekk tieħu żżejjed ta ’ Levemir, dan jista ’ jikkawża livell baxx ta ’ zokkor fid- demm (ipogliċemija).
See the advice in 4 What to do in an emergency.
Ara l- parir f’ 4 X’ għandek tagħmel f’ każ ta ’ emerġenza.
Side effects reported commonly
Effetti sekondarji komuni li ġew irrapportati
(less than 1 in 10)
(inqas minn 1 f’ 10)
Changes at the injection site.
Tibdil fis- sit ta ’ l- injezzjoni.
Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur.
Jistgħu jseħħu reazzjonijiet (ħmura, tinfiħ, infjammazzjoni, ħakk tal - ġilda, u tbenġil) fis- sit ta ’ l- injezzjoni.
These usually disappear after a few weeks of taking your insulin.
Dawn normalment ma jibqgħux jidhru wara li jkun ilek ftit ġimgħat tieħu l- insulina tiegħek.
If they do not disappear see your doctor.
Jekk ma jisparixxux, kellem lit- tabib tiegħek.
If you have serious or continuing reactions, you may need to stop using Levemir and use another insulin.
Jekk ikollok reazzjonijiet serji jew jibqgħu preżenti, jista ’ jkollok bżonn li tieqaf tuża Levemir u tuża insulina oħra.
In three clinical studies in combination with oral antidiabetic agents 2 in 100 subjects reported signs of allergy (for signs of allergy, see below).
Fi tliet studji kliniċi li saru flimkien ma ’ mediċini antidijabetiċi orali 2 minn kull 100 pazjent irrappurtaw sinjali ta ’ allerġija (għal sinjali ta ’ allerġija, ara aktar ’ l isfel)
Side effects reported uncommonly
Effetti sekondarji mhux komuni li ġew irrapportati
(less than 1 in 100)
(inqas minn 1 f’ 100)
Hives and rash may occur.
Fittex parir mediku immedjatament:
Seek medical advice immediately: ► If the above signs of allergy appear, or ► If you suddenly feel unwell, and you: start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy.
Jekk jidhru s- sinjali ta ’ allerġija t’ hawn fuq, jew ► Jekk ma tħossokx tajjeb għall- għarrieda, u int: tibda tixxarrab bl- għaraq; tibda tirremetti; ikollok ► diffikultà biex tieħu n- nifs; ikollok taħbit tal- qalb mgħaġġel; tħossok sturdut.
You may have a very rare serious allergic reaction to Levemir or one of its ingredients (called a generalised allergic reaction).
Int jista ’ jkollok reazzjoni allerġika serja għal Levemir jew għal xi wieħed mill- ingredjenti tiegħu, li hija rari ħafna (din tissejjaħ reazzjoni allerġika ġeneralizzata).
See also the warning in 2 Before you use Levemir.
Ara wkoll it- twissija fi 2 Qabel ma tuża Levemir.
Vision problems.
Problemi tal- vista:
When you first start your insulin treatment, it may disturb your vision, but the disturbance is usually temporary.
Meta tibda t- trattament tiegħek bl- insulina, dan jista ’ jiddisturbalek il- vista, iżda dan id- disturb normalment huwa temporanju.
Changes at the injection site (Lipodystrophy).
Tibdil fis- sit ta ’ l- injezzjoni (Lipodistrofija).
If you inject yourself too often at the same site, fatty tissue under the skin at this site may shrink (lipoatrophy) or thicken (lipohypertrophy).
Jekk tinjetta lilek innifsek ta ’ spiss wisq fl- istess parti, it- tessut tax- xaħam taħt il- ġilda f’ dan is- sit jista ’ jirqaq (lipoatrofija) jew jeħxien (lipoipertrofija).
Changing the site with each injection may help to prevent such skin changes.
Li tibdel is- sit ma ’ kull injezzjoni jista ’ jgħin biex jevita tibdil tal- ġilda bħal dan.
If you notice your skin pitting or thickening at the injection site, tell your doctor or diabetes nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site.
Jekk tinnota ħofor fil - ġilda tiegħek jew li l- ġilda qed teħxien fis- sit ta ’ l- injezzjoni, għid lit- tabib tiegħek jew lin- ners, għax dawn ir- reazzjonijiet jistgħu jsiru iktar serji, jew jistgħu jibdlu l- assorbiment ta ’ l- insulina jekk tinjetta f’ sit bħal dan.
When you start taking insulin, water retention may cause swelling around your ankles and other joints.
Meta tibda tieħu l- insulina, ir- ritenzjoni ta ’ l- ilma tista ’ tikkawża nefħa madwar l - għekiesi u madwar ġogi oħrajn.
This soon disappears.
Dan malajr jisparixxi.
Side effects reported rarely
Effetti sekondarji rari li ġew irrapportati
(less than 1 in a 1,000)
(inqas minn 1 f’ 1000)
Disturbed sensation.
Disturbi fil- mess.
Fast improvement in blood glucose control may cause disturbed sensation (numbness, weakness or pain) in legs or arms.
Titjib mgħaġġel fil- kontroll taz- zokkor fid- demm jista ’ jikkawża disturbi fil- mess (tmewwit, dgħjufija jew uġigħ) fir- riġlejn jew fid- dirgħajn.
These symptoms normally disappear.
Dawn is- sintomi normalment jisparixxu.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f’ dan il- fuljett, jekk jogħġbok għid lit- tabib, lin- ners jew lill- ispiżjar tiegħek.
HOW TO STORE LEVEMIR
KIF TAĦŻEN LEVEMIR
Keep out of the reach and sight of children.
61 Żommu fejn ma jintlaħaqx u ma jidhirx mit- tfal.
Do not use Levemir after the expiry date which is stated on the label and carton.
Tużax Levemir wara d- data ta ’ skadenza li tidher fuq it- tikketta u l- kartuna.
The date refers to the last day of that month.
Id- data ta ’ skadenza tirreferi għall- aħħar ġurnata ta ’ dak ix- xahar.
Levemir Penfill that is not being used is to be stored in the refrigerator at 2°C - 8°C, away from the freezer compartment.
Levemir Penfill li ma jkunx qed jintuża għandu jinħażen fi friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
Levemir Penfill that is being used or carried as a spare is not to be kept in the refrigerator.
Levemir Penfill li jkun qed jintuża jew li qed jinġarr bħala sper m’ għandux jinżamm fi friġġ.
You can carry it with you and keep it at room temperature (not above 30ºC) for up to 6 weeks.
Tista ’ ġġorru miegħek u żżommu fit- temperatura tal- kamra (mhux aktar minn 30ºC) sa perijodu ta ’ 6 ġimgħat.
Keep the cartridge in the outer carton when you ’ re not using it in order to protect it from light.
Żomm l- iskartoċċ fil- kartuna ta ’ barra meta ma tkunx qed tużah sabiex tipproteġih mid- dawl.
Levemir should not be disposed of via waste water or household waste.
Levemir m’ għandux jintrema ma ’ l- ilma tad- drenaġġ jew ma ’ l- iskart domestiku.
Ask your pharmacist how to dispose of medicines no longer required.
Staqsi lill- ispiżjar dwar kif għandek tarmi mediċini li ma għandekx bżonn iżjed.
These measures will help to protect the environment.
Dawn il- miżuri jgħinu għall- protezzjoni l- ambjent.
What Levemir contains
X’ fih Levemir
• The active substance is insulin detemir made by recombinant biotechnology. • The other ingredients are glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections
• Is- sustanza attiva hi insulin detemir magħmula minn bijoteknoloġija rikombinanti. • L- ingredjenti l- oħra huma glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide u ilma għall- injezzjonijiet
What Levemir looks like and contents of the pack
Id- dehra ta ’ Levemir u l- kontenut tal- pakkett
Levemir comes as a clear, colourless, aqueous solution of 1, 5 or 10 cartridges of 3 ml (not all packs may be marketed).
Levemir jiġi bħala soluzzjoni ta ’ ilma ċar u bla kulur ta ’ 1, 5 jew 10 skrataċ mimlijin għal- lest ta ’ 3 ml (jista ’ jkun li mhux il- pakketti kollha jkunu għal skop kummerċjali).
1 ml contains 100 U of insulin detemir.
1 ml fih 100 U ta ’ insulin detemir.
Marketing authorisation holder Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark
Novo Nordisk A/ S Novo Allé DK- 2880 Bagsværd, Id- Danimarka
Manufacturer The manufacturer can be identified by the batch number printed on the slip of the carton and on the label:
Il- manifattur jista ’ jiġi identifikat permezz tan- numru tal- lott ipprintjat fuq il- kartuna u fuq it- tikketta:
Levemir 100 U/ ml solution for injection in a pre-filled pen FlexPen insulin detemir
Levemir 100 U/ ml soluzzjoni għall- injezzjoni f’ pinna mimlija għal- lest FlexPen insulin detemir
Read all of this leaflet carefully before you start using this medicine. – Keep this leaflet.
Aqra dan il- fuljett kollu qabel tibda tuża l- insulina tiegħek. – Żomm dan il- fuljett.
You may need to read it again. – If you have any further questions, ask your doctor, nurse or your pharmacist. – This medicine has been prescribed for you.
Jista ’ jkollok bżonn terġa ’ taqrah. – Jekk ikollok aktar mistoqsijiet, staqsi lit- tabib, lin- ners jew lill- ispiżjar tiegħek. – Din il- mediċina ġiet mogħtija lilek.
It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or your pharmacist.
Tista ’ tagħmlilhom il- ħsara, anki jekk ikollhom l- istess sintomi bħal tiegħek. – Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f’ dan il- fuljett, jekk jogħġbok għid lit- tabib, lin- ners jew lill- ispiżjar tiegħek.
This side of the leaflet
Din in- naħa tal- fuljett
What Levemir is and what it is used for 2.
X’ inhu Levemir u għalxiex jintuża 2.
Before you use Levemir 3.
Qabel ma tuża Levemir 3.
How to use Levemir 4.
Kif tuża Levemir 4.
What to do in an emergency 5.
X’ għandek tagħmel f’ każ ta ’ emerġenza 5.
How to store Levemir 7.
Kif taħżen Levemir 7.
Using your FlexPen
Kif tuża l- FlexPen tiegħek
It comes in a 3 ml pre-filled pen (called FlexPen).
Jiġi f’ pinna mimlija għal- lest ta ’ 3 ml (li tissejjaħ FlexPen).
Look out for the signs of allergy in 5 Possible side effects. ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is symptoms of low blood sugar).
Jekk tħoss li ġejja ipo (ipo hija taqsira ta ’ reazzjoni ipogliċemika u hija sintomu ta ’ livell ► baxx ta ’ zokkor fid- demm).
See 4 What to do in an emergency for more about hypos.
Ara 4 X’ għandek tagħmel f’ każ ta ’ emerġenza, għal aktar informazzjoni dwar l- ipos.
► If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands ► If you are drinking alcohol: watch for signs of a hypo ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin ► If you are going abroad: travelling over time zones may affect your insulin needs
Jekk għandek problemi tal- kliewi jew tal- fwied, jew tal- glandola adrenali, pitwitarja jew tat - ► tirojde Jekk qed tixrob l- alkoħol: oqgħod attent għal sinjali ta ’ ipo ► Jekk qed tagħmel iktar eżerċizzju mis- soltu jew jekk trid tibdel id- dieta normali tiegħek ► Jekk inti marid: kompli ħu l- insulina tiegħek ►
Pregnancy and breast-feeding ► If you are pregnant, planning a pregnancy or breast-feeding please contact your doctor for advice
63 Jekk ser issiefer: li tivvjaġġa fuq medda ta ’ żoni tal- ħin jista ’ jaffettwa l- ħtiġijiet ta ’ l- insulina ► tiegħek
63 Driving and using machines ► If you drive or use tools or machines: watch out for signs of a hypo.
Tqala u Treddigħ Jekk inti tqila, qed tippjana li toħroġ tqila jew qed tredda ’ jekk jogħġbok kellem lit- tabib ► tiegħek għall- parir Sewqan u tħaddim ta ’ magni Jekk issuq jew tuża għodda jew makkinarju: oqgħod attent għal sinjali ta ’ ipo.
Using other medicines
Użu ta ’ mediċini oħrajn
Listed below are the most common medicines, which may affect your insulin treatment.
Elenkati hawn taħt hawn l- iktar mediċini komuni, li jistgħu jaffettwaw it - trattament tiegħek bl- insulina.
Talk about your insulin needs with your doctor and nurse.
Tkellem dwar il- ħtiġijiet ta ’ l- insulina tiegħek mat- tabib tiegħek u man- ners.
• See overleaf for detailed instructions.
• Ara l- paġna ta ’ wara għal struzzjonijiet dettaljati.
Before using Levemir FlexPen
Qabel tuża Levemir FlexPen
► Check the label to make sure it is the right type of insulin ► Always use a new needle for each injection to prevent contamination.
Iċċekkja t- tikketta biex tiżgura li hija t- tip ta ’ insulina x- xierqa ► Dejjem uża labra ġdida għal kull injezzjoni sabiex tevita l- kontaminazzjoni. ►
► In insulin infusion pumps ► If FlexPen is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appears water clear and colourless.
Levemir m’ għandux jintuża F’ pompi ta ’ l- infużjoni ta ’ l- insulina ► Jekk FlexPen jitwaqqa ’, jiġrilu l- ħsara jew jitgħaffeġ, hemm ir- riskju ta ’ telf ta ’ likwidu ta ’ l - ► insulina Jekk ma nħażinx b’ mod korrett jew jekk ġie ffriżat (ara 6 Kif taħżen Levemir) ► Jekk l- insulina ma tidhirx ċara bħall- ilma u bla kulur. ►
The best places to give yourself an injection are: the front of your thighs; the front of your waist (abdomen), or the upper arm.
L- aħjar postijiet minn fejn tinjetta lilek innifsek huma: in- naħa ta ’ quddiem tal- koxox; in- naħa ta ’ quddiem tal- qadd (iż- żaqq), jew fin- naħa ta ’ fuq ta ’ driegħ.
This may happen: • If you take too much insulin • If you eat too little or miss a meal 64 • If you exercise more than usual.
64 Jekk ikollok ipo
If you feel a hypo coming on: take a high sugar snack and then measure your blood sugar.
Jekk jekk tħoss li ġejja ipo: ħu ikla ħafifa li fiha ħafna zokkor u mbagħad kejjel il- livell tal- glukosju fid- demm.
If your blood sugar is too low: eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest.
Jekk il- livell taz- zokkor fid- demm hu baxx ħafna: ħu kapsuli tal- glukosju jew kul ikla ħafifa li fiha ħafna zokkor (ħelu, gallettini, meraq tal- frott), u mbagħad strieħ..
It could choke you. ► If prolonged severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death ► If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor.
Jekk ipogliċemija serja fit- tul ma tkunx ittrattata, din tista ’ tikkawża ħsara fil- moħħ ► (temporanja jew permanenti) u anke l- mewt.
If you are given glucagon you will need glucose or a sugary snack as soon as you are conscious.
Jekk tingħata glucagon inti jkollok bżonn il- glukosju jew inkella kul ikla ħafifa li fiha z - zokkor hekk kif terġa ’ tiġi f’ sensik.
If your blood sugar gets too high
Jekk il- livell taz- zokkor fid- demm jitla ’ żżejjed
Your blood sugar may get too high (this is called hyperglycaemia).
Il- livell taz- zokkor fid- demm tiegħek jista ’ jitla ’ żżejjed (dan jissejjaħ ipergliċemija).
Like all medicines, Levemir can cause side effects, although not everybody gets them.
65 Bħal kull mediċina oħra, Levemir jista ’ jkollu effetti sekondarji, għalkemm ma jidhrux fuq kulħadd.
65 Side effects reported commonly
Effetti sekondarji komuni li ġew irrapportati
Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur.
Jistgħu jseħħu reazzjonijiet (ħmura, nefħa, infjammazzjoni, ħakk tal - ġilda u tbenġil) fis- sit ta ’ l- injezzjoni.
Changes at the injection site (Lipodystrophy).
(Lipodistrofija).
If you notice your skin pitting or thickening at the injection site, tell your doctor or nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site.
Jekk tinnota ħofor fil - ġilda tiegħek jew li l- ġilda qed teħxien fis- sit ta ’ l- injezzjoni, għid lit- tabib tiegħek jew lin- ners, għax dawn ir- reazzjonijiet jistgħu jsiru iktar serji, jew jistgħu jibdlu l- assorbiment ta ’ l- insulina jekk tinjetta f’ sit bħal dan.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or your pharmacist.
Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f’ dan il- fuljett, jekk jogħġbok għid lit- tabib jew lill- ispiżjar tiegħek.
Do not use Levemir after the expiry date which is stated on the label and carton.
66 Tużax Levemir wara d- data ta ’ skadenza li tidher fuq it- tikketta u l- kartuna.
The date refers to the last day of that month.
Id- data ta ’ skadenza tirreferi għal l- aħħar ġurnata ta ’ dak ix- xahar.
Levemir FlexPen that is not being used is to be stored in the refrigerator at 2°C - 8°C, away from the freezer compartment.
Levemir FlexPen li ma jkunx qed jintuża għandu jinħażen fi friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
66 Levemir FlexPen that is being used or carried as a spare is not to be kept in the refrigerator.
Levemir FlexPen li jkun qed jintuża jew li qed jinġarr bħala sper m’ għandux jinżamm fi friġġ.
Always keep the pen cap on your FlexPen when you ’ re not using it in order to protect it from light.
Dejjem żomm it- tapp tal- pinna fuq il- FlexPen tiegħek meta ma tkunx qed tużaha sabiex tilqa ’ mid - dawl.
Levemir should not be disposed of via waste water or household waste.
Levemir m’ għandux jintrema ma ’ l- ilma tad- drenaġġ jew ma ’ l- iskart domestiku ta ’ dar.
Ask your pharmacist how to dispose of medicines no longer required.
Staqsi lill - ispiżjar dwar kif għandek tarmi mediċini li ma għandekx bżonn iżjed.
These measures will help to protect the environment.
Dawn il- miżuri jgħinu għall - protezzjoni l- ambjent.
• The active substance is insulin detemir made by recombinant biotechnology. • The other ingredients are glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections.
• Is- sustanza attiva hi insulin detemir magħmula minn bijoteknoloġija rikombinanti. • L- ingredjenti l- oħra huma glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide u ilma għall- injezzjonijiet
Levemir comes as a clear, colourless, aqueous solution of 1, 5 or 10 pre-filled pens of 3 ml (not all packs may be marketed).
Levemir jiġi bħala soluzzjoni ta ’ ilma ċar u bla kulur ta ’ 1, 5 jew 10 skrataċ mimlijin għal- lest ta ’ 3 ml (jista ’ jkun li mhux il- pakketti kollha jkunu għal skop kummerċjali).
The marketing authorisation holder Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark
Novo Nordisk A/ S Novo Allé DK- 2880 Bagsværd, Id- Danimarka
Now turn over for information on using your FlexPen.
Issa aqleb għal informazzjoni dwar kif tuża l- FlexPen tiegħek.
Introduction
67 Introduzzjoni
Please read the following instructions carefully before using your Levemir FlexPen.
Jekk jogħġbok aqra sew l- istruzzjonijiet li ġejjin qabel ma tuża l- Levemir FlexPen tiegħek.
FlexPen is designed and tested to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Il- FlexPen hi magħmula biex tintuża mal- labar NovoFine jew NovoTwist li jintużaw darba biss u li għandhom tul ta '8 mm jew iqsar.
67 Your Levemir FlexPen Pen cap
Levemir® FlexPen® Tiegħek Għatu tal- pinna
Cartridge Residual
Membrane tal- gomma
Pointer
Skartoċċ
Dose
Skala ta ’ residwu
Push-
Indikatur Selettur Buttuna tad - ta ’ l - doża injezzjoni
membrane
Labra (eżempju)
scale
Għatu l- kbir
selector
Għatu ta ’
Needle (example)
Siġill protettiv
Needle
barra tal - labra
Protective
ġewwa tal - labra
You can clean the exterior of your FlexPen by wiping it with a medicinal swab.
Tista ’ tnaddaf il- parti ta ’ barra tal- FlexPen tiegħek billi timsaħa b’ tajjara b’ diżinfettant.
Preparing your Levemir FlexPen
Kif tipprepara l- Levemir FlexPen tiegħek
A Pull off the pen cap.
A
Disinfect the rubber membrane with a medicinal swab.
Iddiżinfetta l- membrana tal- gomma b’ tajjara mediċinali.
68 Screw the needle straight and tightly onto your FlexPen.
Invita l- labra bi dritt u b' mod issikkat fuq il- FlexPen tiegħek.
Prior to each injection small amounts of air may collect in the cartridge during normal use.
Qabel kull injezzjoni waqt l- użu normali, jistgħu jinġemgħu ammonti żgħar ta ’ arja ġo l - iskartoċċ.
E Turn the dose selector to select 2 units.
69 E Dawwar is- selettur tad- doża sabiex tisselezzjona 2 unitajiet.
69 F Hold your FlexPen with the needle pointing upwards and tap the cartridge gently with your finger a few times to make any air bubbles collect at the top of the cartridge.
F Żomm il- FlexPen tiegħek bil- labra tipponta ’ l fuq u b’ sebgħek tektek bil- mod l- iskartoċċ għal xi ftit drabi, biex jekk ikun hemm xi bżieżaq ta ’ l- arja dawn jinġabru fin- naħa ta ’ fuq ta ’ l- iskartoċċ
If not, change the needle and repeat the procedure no more than six times.
Jekk dan ma jseħħx, ibdel il- labra u rrepeti l - proċedura sa mhux aktar minn 6 darbiet.
H Turn the dose selector to select the number of units you need to inject.
70 Dawwar is- selettur tad- doża sabiex tisselezzjona n- numru ta ’ unitajiet li jkollok bżonn tinjetta
Be careful only to push the push-button when injecting.
Oqgħod attent/ a li tagħfas biss il- buttuna ta ’ l- injezzjoni meta tkun qed/ a tagħmel l- injezzjoni.
71 K
71 J
• Always remove the needle after each injection and store your FlexPen without the needle attached.
K Qiegħed il- labra fl- għatu l- kbir ta ’ barra tal- labra mingħajr ma tmiss l- għatu l- kbir ta ’ barra tal- labra.
Otherwise, the liquid may leak out which can cause inaccurate dosing.
Oqgħod attent kif tarmiha u erġa ’ poġġi lura l- għatu tal- pinna
• Caregivers should be most careful when handling used needles to avoid needle sticks.
• Dejjem neħħi l- labra wara kull injezzjoni u aħżen il- FlexPen tiegħek mingħajr ma l- labra tkun imwaħħla.
72 PACKAGE LEAFLET:
72 FULJETT TA ’ TAGĦRIF:
Levemir 100 U/ ml solution for injection in a pre-filled pen InnoLet insulin detemir
Levemir 100 U/ ml soluzzjoni għall- injezzjoni f’ pinna mimlija għal- lest InnoLet insulin detemir
You may need to read it again. – If you have any further questions, ask your doctor, diabetes nurse or your pharmacist. – This medicine has been prescribed for you.
Jista ’ jkollok bżonn terġa ’ taqrah. – Jekk ikollok aktar mistoqsijiet, staqsi lit- tabib, lin- ners tad- dijabete jew lill- ispiżjar tiegħek. – Din il- mediċina ġiet mogħtija lilek.
It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Tista ’ tagħmlilhom il- ħsara, anki jekk ikollhom l- istess sintomi bħal tiegħek. – Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f’ dan il- fuljett, jekk jogħġbok għid lit- tabib, lin- ners tad- dijabete jew lill - ispiżjar tiegħek.
Using your InnoLet
Kif tuża l- InnoLet tiegħek
It comes in a 3 ml pre-filled pen (called InnoLet).
Jiġi f’ pinna mimlija għal- lest ta ’ 3 ml (li tissejjaħ InnoLet).
Look out for the signs of allergy in 5 Possible side effects. ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is symptoms of low blood sugar).
Jekk tħoss li ġejja ipo (ipo hija taqsira ta ’ reazzjoni ipogliċemika u hija sintomu ta ’ livell baxx ► ta ’ zokkor fid- demm).
Pregnancy and breast-feeding ► If you are pregnant, planning a pregnancy or breast-feeding please contact your doctor for advice 73 Driving and using machines ► If you drive or use tools or machines: watch out for signs of a hypo.
73 Jekk ser issiefer: li tivvjaġġa fuq medda ta ’ żoni tal- ħin jista ’ jaffettwa l- ħtiġijiet ta ’ l- insulina ► tiegħek
Your ability to concentrate or to react will be less during a hypo.
Tqala u Treddigħ Jekk inti tqila, qed tippjana li toħroġ tqila jew qed tredda ’ jekk jogħġbok kellem lit- tabib ► tiegħek għall- parir Sewqan u tħaddim ta ’ magni Jekk issuq jew tuża għodda jew makkinarju: oqgħod attent għal sinjali ta ’ ipo Il- ħila tiegħek ► li tikkonċentra jew tirreaġixxi ser tkun inqas waqt ipo.
Talk about your insulin needs with your doctor and diabetes nurse.
Tkellem dwar il- ħtiġijiet ta ’ l- insulina tiegħek mat- tabib tiegħek u man- ners tad- dijabete.
Before using Levemir InnoLet
Qabel tuża Levemir InnoLet
► In insulin infusion pumps ► If InnoLet is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appear water clear and colourless.
Levemir m’ għandux jintuża F’ pompi ta ’ l- infużjoni ta ’ l- insulina ► Jekk InnoLet jitwaqqa ’, jiġrilu l- ħsara jew jitgħaffeġ, hemm ir- riskju ta ’ telf ta ’ likwidu ta ’ l - ► insulina Jekk ma nħażinx b’ mod korrett jew jekk ġie ffriżat (ara 6 Kif taħżen Levemir) ► Jekk l- insulina ma tidhirx ċara bħall- ilma u bla kulur. ►
This may happen: • If you take too much insulin • If you eat too little or miss a meal 74 • If you exercise more than usual.
74 Jekk ikollok ipo
When symptoms of hypoglycaemia have disappeared or when blood glucose levels are stabilised continue insulin treatment.
Meta s- sintomi ta ’ ipogliċemija jkunu għebu jew meta l- livelli tal- glukosju jkunu stabbilizzaw, kompli bit- trattament ta ’ l- insulina.
If your blood sugar gets too high
Jekk il- livell taz- zokkor fid- demm tiegħek jista ’ jitla ’ żżejjed
Like all medicines, Levemir can cause side effects, although not everybody gets them.
75 Bħal kull mediċina oħra, Levemir jista ’ jkollu effetti sekondarji, għalkemm ma jidhrux fuq kulħadd.
Taking too much Levemir may cause low blood sugar (hypoglycaemia).
Jekk tieħu żżejjed ta ’ Levemir, dan jista ’ jikkawża livell baxx ta ’ zokkor fid- demm ta ’ demm baxx (ipogliċemija).
75 Side effects reported commonly
Effetti sekondarji komuni li ġew irrapportati
Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur.
Reazzjonijiet (ħmura, nefħa, infjammazzjoni, ħakk tal- ġilda u tbenġil) fis- sit ta ’ l- injezzjoni jistgħu jseħħu.
If you have serious or continuing reactions, you may need to stop using Levemir and use another insulin.
Jekk ikollok reazzjonijiet serji jew li jibqgħu preżenti, jista ’ jkollok bżonn li tieqaf tuża Levemir u tuża insulina oħra.
You may have a very rare serious allergic reaction to Levemir or one of its ingredients (called a generalised allergic reaction).
Int jista ’ jkollok reazzjoni allerġika serja għal Levemir jew għal xi wieħed mill- ingredjenti tiegħu, li hija rari ħafna (li tissejjaħ reazzjoni allerġika ġeneralizzata).
If you notice your skin pitting or thickening at the injection site, tell your doctor or diabetes nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site.
Jekk tinnota ħofor fil - ġilda tiegħek jew li l- ġilda qed teħxien fis- sit ta ’ l- injezzjoni, għid lit- tabib tiegħek jew lin- ners tad - dijabete, għax dawn ir- reazzjonijiet jistgħu jsiru iktar serji, jew jistgħu jibdlu l- assorbiment ta ’ l - insulina jekk tinjetta f’ sit bħal dan.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Jekk xi wieħed mill- effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li m’ humiex imsemmijin f’ dan il- fuljett, jekk jogħġbok għid lit- tabib jew lill- ispiżjar tiegħek.
Keep out of the reach and sight of children.
76 Żommu fejn ma jintlaħaqx u ma jidhirx mit- tfal.
Levemir InnoLet that is not being used is to be stored in the refrigerator at 2°C - 8°C, away from the freezer compartment.
Levemir InnoLet li ma jkunx qed jintuża għandu jinħażen fi friġġ f’ temperatura ta ’ 2°C - 8°C, ’ il bogħod mill- kompartiment tal- friża.
Levemir InnoLet that is being used or kept as a spare is not to be kept in the refrigerator.
Levemir InnoLet li jkun qed jintuża jew li qed jinġarr bħala sper m’ għandux jinżamm fi friġġ.
You can 76 carry it with you and keep it at room temperature (not above 30ºC) for up to 6 weeks.
Tista ’ ġġorru miegħek u żżommu fit- temperatura tal- kamra (mhux aktar minn 30ºC) sa perijodu ta ’ 6 ġimgħat.
Always keep the pen cap on your InnoLet when you ’ re not using it in order to protect it from light.
Dejjem żomm il- kappa tal- pinna fuq InnoLet tiegħek meta ma tkunx qed tużah sabiex tilqa ’ mid- dawl.
• The active substance is insulin detemir made by recombinant biotechnology. • The other ingredients are glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections.
• Is- sustanza attiva hi insulin detemir magħmula minn bijoteknoloġija rikombinanti. • L- ingredjenti l- oħra huma glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide u ilma għall- injezzjonijiet.
Levemir comes as a clear, colourless, aqueous solution of 1, 5 or 10 pre-filled pens of 3 ml (not all packs may be marketed).
Levemir jiġi bħala soluzzjoni ta ’ ilma ċar u bla kulur ta ’ 1, 5 jew 10 pinen mimlijin għal- lest ta ’ 3 ml (jista ’ jkun li mhux il- pakketti kollha jkunu għal skop kummerċjali).
The marketing authorisation holder and manufacturer:
Id- detentur ta ’ l- awtorizzazzjoni għat- tqegħid fis- suq u l- manifattur:
Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark
Novo Nordisk A/ S Novo Allé DK- 2880 Bagsværd, Id- Danimarka
Now turn over for information on using your InnoLet.
Issa aqleb għal informazzjoni dwar kif tuża InnoLet tiegħek.
77 INFORMATION ON HOW TO INJECT LEVEMIR INNOLET
77 INFORMAZZJONI FUQ KIF TINJETTA LEVEMIR INNOLET
Please read the following instructions carefully before using your Levemir InnoLet.
Jekk jogħġbok aqra l- istruzzjonijiet li ġejjin b’ attenzjoni qabel ma tuża Levemir InnoLet.
Levemir InnoLet is especially designed to be used with NovoFine S needles of 8 mm or shorter in length.
Levemir InnoLet hija pinna mimlija għal- lest sempliċi u kumpatta li hija kapaċi tagħti minn 1 sa 50 unità b’ żjieda ta ’ 1 unità. Levemir InnoLet hija magħmula b’ mod speċjali biex tintuża mal- labar S NovoFine twal 8 mm jew iqsar.
Look for an S on the needle box.
Sib S fuq il- kaxxa tal- labar.
The S stands for short cap.
S tfisser tapp qasir.
Dose selector dial Residual scale Dose scale
Iċċekkja t- tikketta biex tiżgura li Levemir InnoLet tiegħek fiha t- tip ta ’ insulina x- xieraq.
Compartment for needles
Neħħi l - kappa tal- pinna (kif muri bil- vleġġa).
78 Preparing for injection
78 Kif twaħħal il- labra
• Disinfect the rubber membrane with a medicinal swab • Always use a new needle for each injection to prevent contamination • Remove the protective tab from a NovoFine S needle • Screw the needle straight and tightly onto Levemir InnoLet (picture A). • Always use a new NovoFine S disposable needle for each injection.
• Iddiżinfetta l- membrana tal- gomma b’ tajjara mediċinali. • Dejjem uża labra ġdida għal kull injezzjoni sabiex tevita l- kontaminazzjoni. • Neħħi l- għatu protettiv mil- labra S ta ’ NovoFine • Dawwar il- labra bi dritt u b’ mod marsus fuq Levemir InnoLet (stampa A) • Dejjem uża siringa ġdida NovoFine S li tintrema wara li tintuża għal kull injezzjoni.
Do not bend or damage the needle before use • Pull off the big outer needle cap and the inner needle cap.
Tgħawwiġx u tagħmilx ħsara lil- labra qabel l- użu • Iġbed il- kappa l- kbira ta ’ barra tal- labra u l- kappa ta ’ ġewwa tal- labra.
You may want to store the big outer needle cap in the compartment.
Hemm mnejn int tkun trid terfa ’ l- kappa l- kbira ta ’ barra tal- labra fil- kompartiment.
Priming to expel air prior to each injection
Kif tipprepara biex tneħħi l- arja qabel kull injezzjoni
Small amounts of air may collect in the needle and cartridge during normal use.
Ammonti żgħar ta ’ arja jistgħu jinġemgħu ġol- labra u ġo l- iskartoċċ waqt użu normali.
To avoid injection of air and ensure proper dosing: • Dial 2 units by turning the dose selector clockwise • Hold Levemir InnoLet with the needle upwards and tap the cartridge gently with your finger a few times (picture B) to make any air bubbles collect at the top of the cartridge • Keeping the needle upwards, press the push-button and the dose selector returns to zero • A drop of insulin should appear at the needle tip.
Biex tevita l- injezzjoni ta ’ l- arja u tiżgura dożaġġ korrett: • Iddajlja 2 unitajiet billi ddawwar l- apparat li jagħżel id- doża lejn il- lemin • Żomm Levemir InnoLet bil- labra ppuntata ’ l fuq u taptap fuq l- iskartoċċ b’ subgħajk għal xi drabi (stampa B) biex iġġieħel il- bżieżaq ta ’ l- arja jinġabru fin- naħa ta ’ fuq ta ’ l- iskartoċċ • Filwaqt li żżomm il- labra ’ l fuq, agħfas il- buttuna, u l- apparat li jagħżel id- doża jirritorna fuq iż- żero. • Fit- tarf tal- labra għandha titfaċċa taqtira ta ’ l- insulina.
If not, change the needle and repeat the procedure no more than 6 times.
Jekk dan ma jseħħx, ibdel il- labra u rrepeti l- proċedura mhux iktar minn 6 darbiet.
If a drop of insulin still does not appear, the device is defective and must not be used.
Jekk taqtira ta ’ l- insulina xorta waħda ma titfaċċax, l- apparat huwa difettuż, u m’ għandux jintuża.
79 B
79 Kif tissettja d- doża
Do not use the residual scale to measure your dose of insulin • You will hear a click for every single unit dialled.
• Dejjem iċċekkja li l- buttuna hija magħfusa kemm jista ’ jkun ’ l isfel u li l- apparat li jagħżel id- doża huwa ssettjat fuq iż- żero. • Iddajlja n- numru ta ’ unità meħtieġa billi ddawwar l- apparat li jagħżel id- doża lejn il - lemin( stampa C) Tużax l- iskala residwa biex tkejjel id- doża ta ’ l- insulina tiegħek. • Għandek tisma ’ ċekċika għal kull unità waħda li tiddajlja.
The dose can be corrected by turning the dial either way.
Id- doża tista ’ tiġi regolata billi ddawwar id- dial f’ waħda miż- żewġ direzzjonijiet.
You cannot set a dose larger than the number of units remaining in the cartridge.
Ma tistax tissettja doża ikbar min- numru ta ’ l- unità li jkun fadal fl- iskartoċċ.
• Insert the needle into your skin.
• Daħħal il- labra fil- ġilda tiegħek.
Use the injection technique advised by your doctor • Deliver the dose by pressing the push-button fully down (picture D).
Uża t- teknika ta ’ l- injezzjoni kif spjegata mit- tabib tiegħek. • Agħti d- doża billi tagħfas il- buttuna ’ l isfel kemm tista ’ (stampa D).
You will hear clicks as the dose selector returns to zero • After the injection, the needle should remain under the skin for at least 6 seconds to ensure that the full dose has been delivered • Make sure not to block the dose selector while injecting, as the dose selector must be allowed to return to zero when you press the push-button • Discard the needle after each injection.
Għandek tisma ’ ċ - ċekċik hekk kif l- apparat li jagħżel id- doża jirritorna fuq iż- żero. • Wara l- injezzjoni, il- labra għandha tibqa ’ taħt il- ġilda għal mill- inqas 6 sekondi biex tiżgura li d- doża kollha tkun ingħatat. • Kun żgur li ma timblokkax l- apparat li jagħżel id- doża meta tkun qed tinjetta, minħabba li l- apparat li jagħżel id- doża jrid jitħalla jirritorna fuq iż- żero meta tagħfas il- buttuna • Armi l- labra wara kull injezzjoni.
80 D
80 Kif tneħħi l- labra
• Replace the big outer needle cap and unscrew the needle (picture E).
• Erġa poġġi l- kappa l- kbira ta ’ barra tal- labra u ħoll il- labra (stampa E).
Dispose of it carefully.
Armija b’ attenzjoni.
Be sure to remove and discard the needle after each injection and store Levemir InnoLet without the needle attached.
Kun żgur li tneħħi u tarmi l- labra wara kull injezzjoni u aħżen Levemir InnoLet mingħajr ma l- labra tkun imwaħħla.
Otherwise, the liquid may leak out which can cause inaccurate dosing.
Inkella, il- likwidu jista ’ jnixxi ’ l barra li jista ’ jagħti l- każ li tingħata doża żbaljata.
Health care professionals, relatives and other carers should follow general precautionary measures for removal and disposal of needles to eliminate the risk of unintended needle penetration.
Professjonisti fil- qasam tas- saħħa, qraba u nies oħrajn li jieħdu ħsieb il- pazjent, għandhom isegwu l - miżuri ta ’ prekawzjoni ġenerali għat- tneħħija u r- rimi tal- labar biex jeliminaw ir- riskju ta ’ tingiż ta ’ labar mhux intezjonat.
Dispose of your used Levemir InnoLet carefully without the needle attached.
Armi Levemir InnoLet użat tiegħek b’ attenzjoni mingħajr ma ’ l- labra tkun imwaħħla.
Maintenance
Kif tieħu ħsiebu
Your Levemir InnoLet is designed to work accurately and safely.
81 Levemir InnoLet tiegħek huwa maħsub biex jaħdem bi preċiżjoni u mingħajr periklu.
It should be handled with care.
Għandu jkun immaniġġjat b’ attenzjoni.
If it is dropped, damaged or crushed, there is a risk of leakage of insulin.
Jekk jitwaqqa ’, jiġrilu l- ħsara jew jitgħaffeġ, hemm ir- riskju ta ’ telf ta ’ likwidu ta ’ l- insulina.
As a precautionary measure, always carry a spare insulin delivery device in case your InnoLet is lost or damaged.
Bħala miżura ta ’ prekawzjoni, għandek dejjem iżżomm apparat li jerħi l- insulina sper fil- każ li l - InnoLet tiegħek tintilef jew tiġrilha l- ħsara.
Do not refill Levemir InnoLet.
Terġax timla Levemir InnoLet.
You can clean your Levemir InnoLet by wiping it with a medicinal swab.
Tista ’ tnaddaf in- naħa ta ’ barra ta ’ Levemir InnoLet billi timsaħha b’ tajjara mediċinali.
Do not soak it in surgical spirit or wash or lubricate it.
Tgħaddasx fl - ispirtu u lanqas ma għandek taħsilha jew tagħtiha ż- żejt.
What is Levitra?
X' inhi Levitra?
Levitra is a medicine that contains the active substance vardenafil.
Levitra hija mediċina li fiha s- sustanza attiva vardenafil.
It is available as round, orange tablets (5, 10, or 20 mg).
Tiġi bħala pilloli tondi oranġjo (tal- 5, 10, jew 20 mg).
What is Levitra used for?
Għal xiex tintuża Levitra?
Levitra is used to treat adult men with erectile dysfunction (sometimes called impotence), when they cannot get, or keep, a hard penis (erection) sufficient for satisfactory sexual activity.
Levitra tintuża fit- trattament ta ’ rġiel adulti f' disfunzjoni erettili (imsejħa wkoll impotenza), li tikkonsisti fl- inkapaċità li jilħqu jew iżommu pene iebes (erezzjoni) għal attività sesswali sodisfaċenti.
For Levitra to be effective, sexual stimulation is required.
Biex Levitra jkollha effett, teħtieġ stimulazzjoni sesswali.
How is Levitra used?
Kif tintuża Levitra?
The recommended dose of Levitra is 10 mg, taken with or without food, about 25 to 60 minutes before sexual activity.
Id- doża rakkomandata ta ’ Levitra hija ta ’ 10 mg, meħuda weħidha jew ma ’ l- ikel, bejn 25 u 60 minuta qabel l- attività sesswali.
If Levitra is taken with a high fat meal, the onset of activity may be delayed.
Jekk Levitra tittieħed ma ’ ikla xaħmija ħafna, il- bidu ta ’ l- attività sesswali jista ’ jitbiegħed.
The dose may be increased to a maximum of 20 mg or decreased to 5 mg depending on the effectiveness and side effects.
Id- doża tista ’ tiżdied sa massimu ta ’ 20 mg jew titnaqqas sa 5 mg skond kemm tkun taħdem u l- effetti sekondarji.
Patients with liver problems or severe kidney problems should start treatment on the 5 mg dose.
Il- pazjenti bi problemi fil- fwied għandhom jibdew it- trattament bid- doża tal- 5 mg.
The maximum recommended dosing frequency is one tablet per day.
Il- doża massima rakkomandata hi ta ’ pillola waħda kuljum.
How does Levitra work?
Kif jaħdem Levitra?
The active ingredient of Levitra, vardenafil, belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
L- ingredjent attiv f’ Levitra, vardenafil, jagħmel parti minn grupp ta ’ mediċini magħruf bħala inibituri tal- fosfodjesterażi (phosphodiesterase) tat- tip 5 (PDE5).
It works by blocking the phosphodiesterase enzyme which normally breaks down a substance known as cyclic GMP (cGMP).
Jaħdem billi jimblokka l- enzim fosfodjesterażi li normalment ikisser is- sustanza magħrufa bħala GMP ċikliku (cGMP).
During normal sexual stimulation, cGMP is produced in the penis, where it causes the muscle in the spongy tissue of the penis (the corpora cavernosa) to relax, allowing the inflow of blood in the corpora that produces the erection.
Waqt l - istimulazzjoni sesswali normali, is- cGMP jiġi prodott fil- pene, fejn jikkawża lill- muskolu fit- tessut artab tal- pene (il- corpora cavernosa) jirrilassa, u jippermetti l- fluss tad- demm fil- corpora, u b’ hekk jipproduċi l- erezzjoni.
By blocking the break down of cGMP, Levitra restores erectile function.
Billi jimblokka t- tkissir tas- cGMP, Levitra treġġa 'l- funzjoni ta ’ l- erezzjoni għan- normal.